1-20 of 28
Keywords: Chemotherapy
Close
Sort by
Journal Articles
Gynecol Obstet Invest (2022) 86 (6): 494–501.
Published Online: 18 November 2021
...) and 37 (34.6%) nonfertility-sparing surgery (NFS). Ninety patients received postoperative chemotherapy. Nine of the 43 cases with a lymphadenectomy had metastasis (20.9%). The median follow-up time was 132 months (range, 1–536 months). The overall 5-year and 10-year survival was 95.1% and 91.7...
Journal Articles
Gynecol Obstet Invest (2019) 84 (1): 79–85.
Published Online: 29 January 2019
.... Demographics, stage of breast cancer at diagnosis were similar in the 2 groups. Women with GBC (group 2) were more likely to receive surgery and chemotherapy or surgery alone as compared to those in group 1. No women with GBC received radiation during pregnancy, but 2 received this treatment postpartum...
Journal Articles
Gynecol Obstet Invest (2019) 84 (1): 94–98.
Published Online: 17 July 2018
... of systemic chemotherapy is poor. No biologic or targeted agents have been approved for the management of advanced or recurrent vulvar cancer. Pembrolizumab, a humanized monoclonal antibody against programmed death 1 (PD-1), has been successfully used as a target of tumor immune therapy in small cell lung...
Journal Articles
Gynecol Obstet Invest (2018) 83 (2): 156–163.
Published Online: 20 October 2017
... received this treatment prior to alkylating agent therapy (66 patients). Eleven patients received GnRH agonist before receiving chemotherapy and adjuvant radiotherapy. Among them, 7 patients received total body irradiation, 2 were irradiated in the pelvic region and 2 patients underwent cranial irradiation...
Journal Articles
Journal Articles
Gynecol Obstet Invest (2017) 82 (2): 105–112.
Published Online: 13 September 2016
...:636-641. 26. Fruscio R, Padula F, Mancini E, Pellegrino A, De Nictolis M: Malignant transformation of vaginal endometriosis treated with neoadjuvant chemotherapy and surgery. J Obstet Gynaecol Res 2008;34(4 pt 2):706-708. 27. Mahdavi A, Shamshirsaz AA, Peiretti M, Zakashansky K, Idrees MT...
Journal Articles
Gynecol Obstet Invest (2016) 81 (5): 385–393.
Published Online: 17 June 2016
... were included of whom 33 were females; the median age at presentation was 43. PRC was more common in postmenopausal women. Surgery was the standard therapy; the role of chemotherapy and/or radiotherapy was uncertain. Thirty percent of the patients relapsed after 58 months from the surgery; the rupture...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Gynecol Obstet Invest (1986) 22 (1): 42–46.
Published Online: 15 March 2010
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chemotherapy Epirubicin-cisplatin Cardiotoxicity Myoglobin Gynecol, obstet. Invest. 22: 42-46 (1986) © 1986 S. Karger...
Journal Articles
Gynecol Obstet Invest (1990) 30 (1): 61–63.
Published Online: 02 March 2010
...V. Grover; R.K. Grover; R. Usha; K.B. Logani The authors report a case of pure primary choriocarcinoma of the ovary (FIGO stage III A) in a young patient with 24-month follow-up. The patient, an advanced case of choriocarcinoma, was treated with combination chemotherapy comprising vincristine...
Journal Articles
Gynecol Obstet Invest (1995) 40 (3): 213–214.
Published Online: 01 March 2010
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cervical pregnancy Chemotherapy Liitfi Qamli Hiiseyin §enyurt Hiiseyin Kahramani Bülent Gökmen Ankara State Hospital...
Journal Articles
Gynecol Obstet Invest (1994) 38 (1): 14–17.
Published Online: 01 March 2010
...Ron Tepper; Adrian Shulman; Marco Altaras; Shmuel Goldberger; Ron Maymon; Michael Holzinger; Yoram Beyth Three patients with findings suggestive of invasive gestational trophoblastic neoplasm and lung metastasis were assessed by color Doppler transvaginal ultrasound, before and during chemotherapy...
Journal Articles
Gynecol Obstet Invest (1997) 44 (1): 70–72.
Published Online: 26 February 2010
...Yoshiko Hirota; Kenji Miyamura; Takashi Hayata; Isao Miyakawa We present the unusual case of a 27-year-old Japanese woman who exhibited recurrences of metastatic tumors from uterine leiomyosarcoma after five operations. Chemotherapy with cisplatin, pirarubicin, and cyclophosphamide was ineffective...
Journal Articles
Gynecol Obstet Invest (2004) 58 (4): 186–188.
Published Online: 17 November 2004
... not lead to remission. Second-line chemotherapy, including idarubicin, performed for one cycle, was administrated during the early third trimester of pregnancy. Septic shock occurred due to severe myelosuppression. An emergent cesarean section was performed in response to a nonreassuring pattern...
Journal Articles
Gynecol Obstet Invest (2003) 55 (1): 58–60.
Published Online: 10 March 2003
...-fetoprotein concentration (1,520 ng/ml); histological examination of a needle biopsy specimen revealed a typical yolk sac tumor. Eventually, her initial tumor was diagnosed as a mixed germ cell tumor. The patient was successfully treated with seven courses of chemotherapy and has been disease free for 22...
Journal Articles
Gynecol Obstet Invest (2003) 54 (2): 109–113.
Published Online: 30 January 2003
...-based combination chemotherapy. According to the well-established treatment guidelines for advanced cases, we treated a case of stage IV undifferentiated germ cell tumor in which we were able to preserve the patient’s fertility. We concluded that the PEP regimen is an effective treatment for the patient...